Signalife names Ehrlichman to board, operations director

Signalife has appointed Lee B. Ehrlichman to the company's board of directors and as its director of operations.

Ehrlichman, who oversaw outpatient real-time cardiac telemetry technology and call center monitoring as CEO and president of Cardiac Telecom, will oversee company operations as Signalife’s operations director, a consulting position. In the position, he will monitor all production activities and allow timely deliveries of product, overseeing regulatory activities, as well as research and development actions, the Greenville, S.C.-based company said.

As operations director, Ehrlichman is expected to operate out of the company’s Los Angeles offices and laboratory facilities on a full-time basis, Signalife said. The company also said that Ehrlichman will take a lead role in company sales, both in the remote cardiac monitoring market as well as traditional ECG markets.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.